One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Tumor-Treating Fields Open the Door to Progress for Patients With Locally Advanced Pancreatic Cancer.
doi : 10.1200/JCO-25-01040
Volume 43(21) pgs. 2339-2451 July 20, 2025
Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non-Small Cell Lung Cancer (IMpower010): An Open-Label, Randomized, Phase III Trial.
doi : 10.1200/JCO-24-01681
Survival Benefit of Palliative Oophorectomy for Patients With Ovarian Metastasis From Baseline Metastatic Gastric Adenocarcinoma.
doi : 10.1200/JCO-24-01678
Mindfulness and Tai Chi for Cancer Health (MATCH) Study: Primary Outcomes of a Preference-Based Multisite Randomized Comparative Effectiveness Trial.
doi : 10.1200/JCO-24-02540
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma.
doi : 10.1200/JCO-25-00759
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma.
doi : 10.1200/JCO-24-02424
Calibrating Chimeric Antigen Receptor (CAR) Signaling to Improve CAR T-Cell Therapies.
doi : 10.1200/JCO-24-02792
Nephrotoxicity Surveillance for Childhood and Young Adult Survivors of Cancer: Recommendations From the International Late Effects of Childhood Cancer Guideline Harmonization Group.
doi : 10.1200/JCO-24-02534
Reply to: Comment on The Study of NRG258: Limitations and Future Directions.
doi : 10.1200/JCO-25-00473
